United States (US) Haemophilia Market (2025-2031) | Segmentation, Analysis, Competitive Landscape, Value, Industry, Size & Revenue, Forecast, Outlook, Companies, Trends, Share, Growth
Market Forecast By Treatment (Medication, Desmopressin, Emicizumab, Anti-fibrinolytics, ITI Therapy, Gene Therapy, Fibrin Sealants, Others), By Route of Administration (Oral, Injectable, Others), By Diagnosis (Blood Test, Genetic Tests, Others), By Patient (Pediatric, Adult), By Type (Haemophilia A, Haemophilia B, Haemophilia C, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) And Competitive Landscape
| Product Code: ETC9967291 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Key Highlights of the Report:
- United States (US) Haemophilia Market Outlook
- Market Size of United States (US) Haemophilia Market, 2024
- Forecast of United States (US) Haemophilia Market, 2031
- Historical Data and Forecast of United States (US) Haemophilia Revenues & Volume for the Period 2021- 2031
- United States (US) Haemophilia Market Trend Evolution
- United States (US) Haemophilia Market Drivers and Challenges
- United States (US) Haemophilia Price Trends
- United States (US) Haemophilia Porter's Five Forces
- United States (US) Haemophilia Industry Life Cycle
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Treatment for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Medication for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Desmopressin for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Emicizumab for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Anti-fibrinolytics for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By ITI Therapy for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Gene Therapy for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Fibrin Sealants for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Medication Haemophilia Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Route of Administration for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Oral for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Injectable for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Diagnosis for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Blood Test for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Genetic Tests for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Patient for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Pediatric for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Adult for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Type for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Haemophilia A for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Haemophilia B for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Haemophilia C for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By End-Users for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Hospitals for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Homecare for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Haemophilia Market Revenues & Volume By Others for the Period 2021- 2031
- United States (US) Haemophilia Import Export Trade Statistics
- Market Opportunity Assessment By Treatment
- Market Opportunity Assessment By Route of Administration
- Market Opportunity Assessment By Diagnosis
- Market Opportunity Assessment By Patient
- Market Opportunity Assessment By Type
- Market Opportunity Assessment By End-Users
- Market Opportunity Assessment By Distribution Channel
- United States (US) Haemophilia Top Companies Market Share
- United States (US) Haemophilia Competitive Benchmarking By Technical and Operational Parameters
- United States (US) Haemophilia Company Profiles
- United States (US) Haemophilia Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6Wresearch actively monitors the United States (US) Haemophilia Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Haemophilia Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Haemophilia Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Haemophilia Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Haemophilia Market - Industry Life Cycle |
3.4 United States (US) Haemophilia Market - Porter's Five Forces |
3.5 United States (US) Haemophilia Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 United States (US) Haemophilia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United States (US) Haemophilia Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 United States (US) Haemophilia Market Revenues & Volume Share, By Patient, 2021 & 2031F |
3.9 United States (US) Haemophilia Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 United States (US) Haemophilia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 United States (US) Haemophilia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Haemophilia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about haemophilia and its treatment options among patients and healthcare professionals. |
4.2.2 Technological advancements leading to the development of innovative treatments and therapies for haemophilia. |
4.2.3 Rising prevalence of haemophilia in the United States, leading to a growing patient population. |
4.2.4 Government initiatives and policies supporting access to haemophilia treatment and care. |
4.2.5 Growing investments in research and development by pharmaceutical companies to improve haemophilia treatment options. |
4.3 Market Restraints |
4.3.1 High cost associated with haemophilia treatment and therapies, limiting access for some patients. |
4.3.2 Challenges in diagnosis and management of haemophilia, leading to underdiagnosis and suboptimal treatment. |
4.3.3 Potential side effects and complications associated with haemophilia treatments, affecting patient adherence and outcomes. |
4.3.4 Regulatory hurdles and approval processes for new haemophilia treatments, leading to delays in market entry. |
4.3.5 Competition from alternative treatment options and therapies for haemophilia, impacting market share. |
5 United States (US) Haemophilia Market Trends |
6 United States (US) Haemophilia Market, By Types |
6.1 United States (US) Haemophilia Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Haemophilia Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 United States (US) Haemophilia Market Revenues & Volume, By Medication, 2021- 2031F |
6.1.4 United States (US) Haemophilia Market Revenues & Volume, By Desmopressin, 2021- 2031F |
6.1.5 United States (US) Haemophilia Market Revenues & Volume, By Emicizumab, 2021- 2031F |
6.1.6 United States (US) Haemophilia Market Revenues & Volume, By Anti-fibrinolytics, 2021- 2031F |
6.1.7 United States (US) Haemophilia Market Revenues & Volume, By ITI Therapy, 2021- 2031F |
6.1.8 United States (US) Haemophilia Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.1.9 United States (US) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 United States (US) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Haemophilia Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Haemophilia Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 United States (US) Haemophilia Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 United States (US) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Haemophilia Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Haemophilia Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.3.3 United States (US) Haemophilia Market Revenues & Volume, By Genetic Tests, 2021- 2031F |
6.3.4 United States (US) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Haemophilia Market, By Patient |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Haemophilia Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4.3 United States (US) Haemophilia Market Revenues & Volume, By Adult, 2021- 2031F |
6.5 United States (US) Haemophilia Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Haemophilia Market Revenues & Volume, By Haemophilia A, 2021- 2031F |
6.5.3 United States (US) Haemophilia Market Revenues & Volume, By Haemophilia B, 2021- 2031F |
6.5.4 United States (US) Haemophilia Market Revenues & Volume, By Haemophilia C, 2021- 2031F |
6.5.5 United States (US) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Haemophilia Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Haemophilia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United States (US) Haemophilia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 United States (US) Haemophilia Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 United States (US) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7 United States (US) Haemophilia Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 United States (US) Haemophilia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 United States (US) Haemophilia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 United States (US) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 United States (US) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Haemophilia Market Import-Export Trade Statistics |
7.1 United States (US) Haemophilia Market Export to Major Countries |
7.2 United States (US) Haemophilia Market Imports from Major Countries |
8 United States (US) Haemophilia Market Key Performance Indicators |
8.1 Average time to diagnosis of haemophilia in the United States. |
8.2 Patient adherence rates to prescribed haemophilia treatments. |
8.3 Number of clinical trials for new haemophilia treatments conducted in the United States. |
8.4 Patient satisfaction scores with haemophilia treatment and care services. |
8.5 Rate of adoption of innovative haemophilia treatment options among healthcare providers in the United States. |
9 United States (US) Haemophilia Market - Opportunity Assessment |
9.1 United States (US) Haemophilia Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 United States (US) Haemophilia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United States (US) Haemophilia Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 United States (US) Haemophilia Market Opportunity Assessment, By Patient, 2021 & 2031F |
9.5 United States (US) Haemophilia Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 United States (US) Haemophilia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 United States (US) Haemophilia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Haemophilia Market - Competitive Landscape |
10.1 United States (US) Haemophilia Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Haemophilia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Global Go To Market Strategy - 2030
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here
Pricing
- Single User License$ 1,995
- Department License$ 2,400
- Site License$ 3,120
- Global License$ 3,795
Leadership Perspectives from Industry Events
Search
6Wresearch in the News
Forbes
Citing 6Wresearch analytics to map global infrastructure and pharmaceutical industry trajectories.
Bloomberg Law
Direct syndication of 6Wresearch's macro data points, capturing complex supply chain shifts.
Reuters
Tracking industrial manufacturing adjustments and electronic security ecosystem scaling.
Mint
Utilizing deep-tech sector market sizing to analyze global automation and robotics.
The Economic Times
Anchoring features on industrial IoT growth metrics and connected smart-grid devices.
Business Standard
Featuring strategic evaluations of Advanced Driver Assistance Systems (ADAS) and AI road safety.
The Hindu
Spotlighting core commercial metrics ranging from unmanned aerial vehicles (UAVs) to consumer durables.
Financial Express
Anchoring quarterly reviews on cross-border real estate tech and structural hardware manufacturing.
Yahoo Finance
Syndicating the tracker's $30.1 billion untapped-market findings, spotlighting Japan, the US and China as India's top new-potential importers.
India Today
Carrying the release on smartphones leading India's export potential to $94 billion by 2031, per 6WExportGTM data.
Dailyhunt
Distributing the tracker findings to its regional readership, framing India's export diversification into Japan and Mexico.
PR Newswire Original release
Publishing the full India Export Attractiveness Tracker 2026, detailing new trade corridors across iron ore, LCVs and pharmaceuticals.
The Industrial
Highlighting the tracker's read on India's semiconductor ambitions and long-term chip-assembly export potential.
PTI News
Reporting on the $66.81 billion pharmaceuticals export opportunity flagged in the tracker, amid looming US generic-drug tariffs.
Tribune India
Covering the tracker's tariff-versus-regulation analysis across India's mature export markets in the US, China and UAE.
ANI News
Amplifying the report's findings on polished diamonds, refined petroleum and medicines as India's core export engines.
International Business Magazine
Covering the report's insight into how AEB, blind spot detection, and driver monitoring are reshaping India's ADAS market.
Focus Gaming News
Highlighting the research forecast for Egypt's gambling market, projecting steady growth through 2032.
Thought Leadership and Analyst Meet
Our Clients
Latest Reports
- Poland Engine Ignition Components Market (2026-2032)
- Peru Engine Ignition Components Market (2026-2032)
- Pakistan Engine Ignition Components Market (2026-2032)
- Oman Engine Ignition Components Market (2026-2032)
- Nigeria Engine Ignition Components Market (2026-2032)
- Nepal Engine Ignition Components Market (2026-2032)
- Myanmar Engine Ignition Components Market (2026-2032)
- Morocco Engine Ignition Components Market (2026-2032)
- Mexico Engine Ignition Components Market (2026-2032)
- Malaysia Engine Ignition Components Market (2026-2032)
Industry Events and Analyst Meet
EV India Expo 2026
HIMTEX 2026
India Refining Summit 2026
India EV Show 2026
EV tech India Expo 2026
Whitepaper
- Middle East & Africa Commercial Security Market Click here to view more.
- Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more.
- GCC Drone Market Click here to view more.
- Middle East Lighting Fixture Market Click here to view more.
- GCC Physical & Perimeter Security Market Click here to view more.
